This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Rinfret S, Cohen DJ, Tahami Monfared AA, Lelorier J, Mireault J, Schampaert E.Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial. American Journal of Cardiovascular Drugs 6: 159-168, No. 3, 2006
About this article
Cite this article
SES cost effective in high-risk patients in Canada. Pharmacoecon. Outcomes News 509, 4 (2006). https://doi.org/10.2165/00151234-200605090-00009
- Percutaneous Coronary Intervention
- Coronary Artery Bypass Graft
- Coronary Artery Bypass Graft Surgery
- Absolute Risk Reduction
- Repeat Revascularisation